
Sarah Nagle, MD, assistant professor of medicine, School of Medicine, Oregon Health & Science University, discusses investigational cellular therapies in multiple myeloma.

Your AI-Trained Oncology Knowledge Connection!


Sarah Nagle, MD, assistant professor of medicine, School of Medicine, Oregon Health & Science University, discusses investigational cellular therapies in multiple myeloma.

Sarah Nagle, MD, discusses the evolution of daratumumab administration in multiple myeloma.

Sarah Nagle, MD, discusses sequencing challenges in multiple myeloma.